A Win For Heat Biologics, Inc.

Heat Biologics, Inc. (HTBX:NASDAQ) soared at $0.77, representing a gain of 26.9%. On Mon 18 May 20, HTBX:NASDAQ hit a New 2-Week High of $0.6. The stock got featured on our News Catalysts scanner on Mon 18 May 20 at 01:13 PM in the 'BIOTECH' category. From Mon 04 May 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Thu 05 Mar 20 at $1.25 with a volume of 146M+, and its share price has been moving sideways in recent weeks.
About Heat Biologics, Inc. (HTBX:NASDAQ)
Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, 'off-the-shelf' cellular therapeutic vaccines to combat various cancers and infectious diseases.
Top 10 Gainers:
- Nano Dimension Ltd. (NNDM:NASDAQ), 341.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 51.64%
- AeroCentury Corp. (ACY:NYSEMKT), 37.97%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 37.86%
- Dynavax Technologies Corporation (DVAX:NASDAQ), 33.95%
- ArTara Therapeutics, Inc. (TARA:NASDAQ), 32.75%
- I-Mab (IMAB:NASDAQ), 31.56%
- Acer Therapeutics Inc. (ACER:NASDAQ), 29.43%
- Iterum Therapeutics plc (ITRM:NASDAQ), 26.96%
- Heat Biologics, Inc. (HTBX:NASDAQ), 26.87%